dr. peters on the flaura trial for egfr-mutated nsclc
Published 6 years ago • 421 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
1:29
dr. fidler on the flaura trial in egfr-mutant nsclc
-
2:09
dr. hassan on flaura trial results in egfr-mutant nsclc
-
1:59
the flaura trial in egfr nsclc
-
2:34
dr. ramalingam on flaura findings in egfr-mutant nsclc
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
15:03
symptom management | 2023 living with egfr-mutant lung cancer patient forum
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
7:00
flaura trial: impact of os data in advanced nsclc
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
5:42
osimertinib and the flaura trial
-
9:36
the flaura trial: practice-changing results for egfr mutation-positive nsclc (bmic-007)
-
1:19
dr. ramalingam on the significance of the flaura trial in nsclc
-
1:05
dr. ramalingam on the activity of osimertinib combinations in nsclc
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
1:21
dr. kris on the fda approval of dacomitinib in egfr nsclc
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
1:23
flaura trial demonstrates efficacy in egfr-positive lung cancer
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
0:57
examining the impact of the flaura trial in egfr-mutant nsclc
-
1:10
dr. gubens on prevalence of egfr/alk/ros1 and pd-l1 expression in nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc